[18F]FES PET/CT offers a valuable approach for patients with ER-positive, well-differentiated, or lobular breast cancer, which often presents with low [18F]FDG uptake and may be challenging to evaluate with standard imaging techniques. The gene discussed is ESR1; the disease is Hereditary breast cancer.